Financial Results for Mar 31, 2010 & Jun 30, 2010
Marksans Pharma Ltd has informed BSE about the Audited Financial Results for the Year ended March 31, 2010 & Financial Results for the Quarter ended June 30, 2010.12-08-2010
12-08-2010
Updates
Marksans Pharma Ltd has informed BSE that, pursuant to the resolution passed by the Shareholders of the Company through voting by postal ballot which was announced on February 02, 2010, the Company has entered into a Business Transfer Agreement on July 28, 2010 with Kores (India) Limited for sale and transfer of its Active Pharmaceutical Ingredient (API) business together with the manufacturing facilities located at Plot No. A88 & Plot No. D10, M.I.D.C.,...29-07-2010
Limited Review for the quarter ended March 31, 2010
Marksans Pharma Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended March 31, 2010.14-05-2010
Financial Results for Mar 31, 2010
Marksans Pharma Ltd has informed BSE about the Financial Results for the Quarter & Year ended March 31, 2010.07-05-2010
Conversion of Foreign Currency Convertible Bonds into Equity Shares
Marksans Pharma Ltd has informed BSE that pursuant to the approval of the shareholders of the Company at the Extra Ordinary General Meeting held on May 12, 2005 and Offering Circular dated November 07, 2005, the Company had issued US$ 50 Million through Foreign Currency Convertible Bonds (Bond) on October 13, 2005. These bonds are convertible into the underlying equity shares at the option of the bond holders....14-04-2010
Limited Review for the quarter ended Dec 31, 2009
Marksans Pharma Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2009.03-03-2010
Marksans Pharma - Result of Postal Ballot
Marksans Pharma Ltd has informed BSE that the members of the Company, by way of Postal Ballot, have approved both the following resolutions, as set out in the notice, with requisite majority:1. An Ordinary Resolution under Section 293(1)(a) of the Companies Act, 1956 relating to sale, lease or otherwise disposal of the API Plants of the Company located at Plot No. A88 & D10, Kurkumbh, MIDC, Pune, and...03-02-2010
Marksans Pharma - Financial Results for Dec 31, 2009
Marksans Pharma Ltd has informed BSE about the financial results for the Quarter ended December 31, 2009.29-01-2010
Marksans Pharma - Notice of Postal Ballot
Marksans Pharma Ltd has informed BSE that the members of the Company will consider to approve by way of Postal Ballot the following resolutions:1. Authority to the Board of Directors ("the Board") of the Company to sell, lease or otherwise dispose of the Company's Active Pharmaceutical Ingredient plants located at Plot No. A88 & D10, Kurkumbh, MIDC, Pune (API Plants) to any suitable party / parties at such consideration and with effect from...06-01-2010